Market intelligence
Fast, evidence-led coverage of the companies and events moving global markets.
All coverage
DUBLIN, California, August 21, 2026, 17:03 PDT — Ross Stores shares jumped after the discount retailer added $3.2 billion in value, with a tariff…
| Firm | Call | Target |
|---|---|---|
| Deutsche Bank | Buy | $294 |
| Evercore ISI | Outperform | $290 |
| Jefferies | Buy | $285 |
| Telsey | Outperform | $280 |
| Morgan Stanley | Equal Weight | $234 |
| 20-analyst average | Buy | $269.94 |
BitMine Immersion Technologies, Inc. closed Friday with shares at $22.83, marking a 5.8% increase and bringing its market capitalization to $13.77 billion. However, a…
| ETH staked | 5.067M | 87% |
| 7-day annualized yield | 2.61% | Company figure |
| Projected current staking revenue | $250M | Annualized |
| Shares repurchased since July | 20.8M+ | Share count matters |
| 1 | Weekend Ether close versus $2,520 reference |
| 2 | Opening gap versus $22.83 stock close |
| 3 | Next weekly ETH and buyback disclosure |
| Risk | Crypto reversal, custody, slashing or dilution |
MP Materials Corp. surged 9.14% on Friday, recouping much of its losses from earlier in the week. The stock ended the day at $60.07,…
| Q2 metric | 2026 | YoY |
|---|---|---|
| Revenue | $108.5M | +89% |
| Adjusted EBITDA | $28.5M | +$41.0M |
| NdPr production | 840 MT | +41% |
| NdPr sales | 1,006 MT | +127% |
| REO production | 11,072 MT | -16% |
| Measure | Value | Vs. close |
|---|---|---|
| Low target | $58.00 | -3.4% |
| Average target | $75.38 | +25.5% |
| Median target | $75.00 | +24.9% |
| High target | $100.00 | +66.5% |
| Consensus | Strong Buy | 18 analysts |
Friday's 9.14% rebound left MP only 2.26% higher for the week. The operating case is improving, but the earnings bridge remains policy-sensitive: Q2 price-protection income equaled nearly two-thirds of adjusted EBITDA.
Rare-earth trade policy
Independence magnet qualification
10X construction progress
Follow-through after high-volume rally
Sources: Nasdaq market data; MP Materials Q2 2026 results; S&P Global analyst data via StockAnalysis, last updated August 19, 2026. Adjusted EBITDA is non-GAAP. Percentages are calculated from reported figures and may vary slightly due to rounding.
CSL Limited added an estimated A$16.1 billion in market value during results week. The shares ended Friday at A$168.30, up 25.0% from Monday's A$134.60…
| Broker | Call | Target |
|---|---|---|
| UBS | Buy | A$181 |
| CLSA | Outperform | A$180 |
| Macquarie | Hold | A$108 |
| Current aggregate | Buy | A$163.62 |
Weekly Recap and Week Ahead: Healthcare Leads, CPI Looms08.22.2026 · 08:37 AEST WEEKEND EDITION · CASH MARKET CLOSED Weekly Recap + Week Ahead Healthcare…
Shares in Picard Medical, Inc. saw trading volume reach 4.47 million on Friday, marking a 54-fold surge compared to Thursday. The stock finished up…
| Date | Close | Move | Volume |
|---|---|---|---|
| Aug. 17 | $3.52 | -0.3% | 49K |
| Aug. 18 | $3.24 | -8.0% | 60K |
| Aug. 19 | $3.29 | +1.5% | 69K |
| Aug. 20 | $3.03 | -7.9% | 82K |
| Aug. 21 | $3.21 | +5.9% | 4.47M |
| Watch | Financing terms and dilution |
| Watch | NYSE American compliance milestones |
| Proof point | Sustained positive gross margin |
| Risk | March cash was only $121,000 |
Dogecoin jumped following a White House crypto meeting that revived expectations for more transparent U.S. market regulations. The meme coin’s sharp rally now serves…
Dogecoin led Bitcoin over the past week, while Coinbase finished Friday 25.6% above its August 14 close. The next signal is turnover: lasting volume can help transaction revenue; a fast price reversal cannot.
| Operating marker | Q2 2026 | Read-through |
|---|---|---|
| Transaction revenue | -21% q/q | Trading softness was visible |
| Trading-volume share | 10.3% | Record; up from 9.1% |
| Subscription/services mix | 48% of net revenue | Buffers fee volatility |
| Adjusted EBITDA | 14th positive quarter | Cost discipline held |
| Buy / Hold / Sell | 22 / 9 / 3 |
|---|---|
| Consensus | Buy |
| Average target | $195.52 · 4.8% above close |
| Median target | $185.00 · 0.8% below close |
| Low / High | $95 / $330 |
Shares of Applied Optoelectronics, Inc. fell 10.2% to $112.11 in late Friday trade. The decline came after the company announced a new $600 million…
NASDAQ: AAOI · Investor snapshot
Applied Optoelectronics, Inc. · U.S. market closed Friday, August 21, 2026
-3.32% Friday
Closed August 21 at 4:00 p.m. EDT.
-9.83% vs. close
Nasdaq last sale at 6:25 p.m. EDT. Extended-hours prices can be thin.
Raymond James and Needham may sell shares over time. AOI is not required to use it.
2% sales commissionAt Friday's close, equal to 5.7% of the 84.91 million shares outstanding on August 20.
The balance sheet is liquid, but capacity expansion consumes cash quickly. The new authorization is 1.18× June cash plus restricted cash.
Midpoint implies 42.0% sequential growth. Management says demand may exceed capacity through mid-2027.
Consensus: Buy from six analysts. Three were Holds. Targets were last updated before the ATM filing.
The SEC illustration is mechanical, not a forecast. Actual prices and issued shares will vary.
Equity funds the 800G and 1.6T ramp. Q3 revenue reaches or exceeds the $272.5 million midpoint.
AOI sells gradually. Investors weigh added capacity against a persistent supply overhang.
Weak pricing forces more shares into the market while production delays or customer timing slow the ramp.
Sources: August 21 Form 8-K, prospectus supplement, Q2 Form 10-Q, company Q2 release, S&P Global analyst data via StockAnalysis, and Nasdaq market data. Calculations use displayed figures and may differ due to rounding.
BHP Group Limited wrapped up results week posting a valuation increase estimated at A$19.4 billion. The stock finished Friday at A$65.16, marking a 6.2%…
| Measure | FY26 | Change |
|---|---|---|
| Revenue | US$58.76bn | +15% |
| Underlying EBITDA | US$32.95bn | +27% |
| Operating cash flow | US$21.78bn | +17% |
| Free cash flow | US$9.8bn | +83% |
| Net debt | US$8.69bn | -33% |
| Annual dividend | US$1.72/share | 4-year high |
Archer Aviation Inc. rose 3.45% on Friday, but the stock finished a turbulent week 4.83% lower at $6.30.
Fidelity Wise Origin Bitcoin Fund attracted $64.74 million on Thursday. However, BlackRock, Inc. dominated fresh inflows, with its IBIT fund pulling in $502.99 million—accounting…
Shares of Critical Metals Corp. jumped 22.6% on Friday. The stock, however, closed at $7.11, remaining under the important $8 merger benchmark. As a…
Market data as of August 21, 2026, 16:00 EDT
| View | Rating | Target | Upside |
|---|---|---|---|
| Freedom | Hold | $8 | 12.5% |
| S&P consensus | Hold | $13 | 82.8% |
| Cantor | Spec. Buy | $18 | 153.2% |
RF Acquisition Corp II jumped 355.6% on Friday after shareholders approved its proposed combination with Nanyang Biologics. The shares closed at $58.00 after trading…
Moderna, Inc. closed its most turbulent week since the pandemic at $145.13. The stock rose 8.86% on Friday, following two days of sharp gains…
Moderna · NASDAQ:MRNA
Day range $132.42–$159.47 · Volume 86.74M vs. 15.08M average
$62.96 before the readout to $145.13 Friday.
$82.17 per share × 399.24M shares.
About 8.4× June cash and investments.
Before the $950M litigation payment made in July.
INTerpath-001 enrolled 1,137 melanoma patients and met recurrence-free and distant-metastasis-free survival endpoints. No new safety signal emerged. The full Phase 3 hazard ratios, confidence intervals, subgroup results and overall-survival data remain undisclosed. Investors have added $32.81 billion of equity value without the effect size.
Risk: the price can reverse if detailed efficacy, safety or regulatory timing falls short of the expectations embedded in the rally.
Sources: Google Finance · Phase 3 release · SEC Q2 filing
Boston Scientific Corporation gained 2.03% on Friday, recovering under 40% of Thursday’s decline. Shares settled at $50.37 at 16:00:02 EDT. Trading volume was 31.76…
| Measure | Q2 2026 | Growth |
|---|---|---|
| Net sales | $5.442B | +7.5% |
| Adjusted EPS | $0.86 | +14.7% |
| Cardiovascular | $3.624B | +8.3% |
| MedSurg | $1.818B | +5.9% |
| Rating | Mar. | Aug. |
|---|---|---|
| Strong Buy | 24 | 18 |
| Buy | 10 | 8 |
| Hold | 0 | 5 |
| Sell | 0 | 0 |
SELLAS Life Sciences Group, Inc. climbed 15.37% on Friday, ending the session at $15.46 — just 2.6% shy of its 12-month peak. The surge…
| Q2 net loss | $9.6M |
| Q2 R&D | $6.3M |
| Cash / share | $0.68 |
| Shares outstanding | 201.9M |
| Share-count growth | +31.9% |
![Australia Stock Market Today 22/08/2026 [UPDATE: 08:37 AEST] [Weekly Recap and Week Ahead: Healthcare Leads, CPI Looms]](https://ts2.tech/wp-content/uploads/2026/08/AU-market-dashboard-2026-08-22-0837-1024x683.jpg "Australia Stock Market Today 22/08/2026 [UPDATE: 08:37 AEST] [Weekly Recap and Week Ahead: Healthcare Leads, CPI Looms]")
